Last reviewed · How we verify
Splint Versus Steroid Injection for DeQuervain's Tenosynovitis: A Randomized Trial
The primary aim is to compare the effectiveness of splinting versus steroid injection in improving the DASH scores in participants diagnosed with De Quervain's tenosynovitis over a period of 6 months.
Details
| Lead sponsor | National University Hospital, Singapore |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 100 |
| Start date | 2022-06 |
| Completion | 2024-02 |
Conditions
- De Quervain Syndrome
Interventions
- Hydrocortisone-Lidocaine
- Splint
Primary outcomes
- Quick Disability of Arm, Shoulder, Hand (QuickDASH) — 6 months
Our co- primary outcome would be QuickDash. QuickDash is a disability score we use for the upper limb where the higher score indicates greater disability and severity. We would expect a decrease in QuickDash scores following a success in the treatment measure. The resultant score is reported on a scale of 0 to 100, where 0 represents no disability and 100 represents total disability - Patients who have recovered from De Quervain's Tenosynovitis — 6 months
The other primary outcomes would be the number of patients who have completely recovered from De Quervain's tenosynovitis. This will be determined by the global improvement the patient feels that will be ranked on a 7 point Likert scale (1: very much worse, 2: much worse, 3:slightly worse, 4:no change, 5:slightly better, 6:much better, 7:completely resolved).